Clinical Trials Sponsored by Vaxtrials S.A.

Total 3188 results

Spanish Oncology Genito-Urinary Group
Roche Farma, S.A; Dynamic Science S.L.

Active, not recruiting

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

Bladder Cancer

Spain
Volumina Medical S.A.

Not yet recruiting

Evaluation of Safety of Filler Injection in Subcutaneous Tissues

Volume Deficiency

Switzerland
Polpharma Biologics S.A.

Not yet recruiting

Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® (UCESIVE)

Ulcerative Colitis
ADC Therapeutics S.A.

Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)

Diffuse Large B-Cell Lymphoma | High-grade B-cell Lymphoma

Taiwan, Korea, Republic of, United States, Brazil
NAOS Argentina S.A.

Recruiting

Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream Intended for Very Dry, Irritated to Atopic Sensitive Skin.

Atopic Dermatitis | Eczema, Atopic

Argentina, Singapore
Eurofarma Laboratorios S.A.

Not yet recruiting

Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children (DESPRED)

Allergic Rhinitis

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight (UNLIMITED)

Obesity | Overweight

Brazil
Eurofarma Laboratorios S.A.

Not yet recruiting

Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/Topiramate in Overweight Comorbidities/Obesity (TOLERASIT)

Obesity | Overweight

Brazil
Addex Pharma S.A.

Recruiting

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
Addex Pharma S.A.

Recruiting

Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm

Dystonia | Blepharospasm

United States
Eurofarma Laboratorios S.A.

Recruiting

Fixed Dose Combination of COdeine + DIpyrone to Mitigate Moderate to Intense Pain Post-impacted Third Lower Molar Extraction (CODI)

Pain

Brazil
Addex Pharma S.A.

Recruiting

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
EDAP TMS S.A.

Recruiting

Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.

Benign Prostatic Hyperplasia

France
Apsen Farmaceutica S.A.

Recruiting

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction (CARLOTA)

Postsurgical Pain | Third Molar Extraction

Brazil
EDAP TMS S.A.

Recruiting

Evaluation of High Intensity Focused Ultrasound (HIFU) in the Treatment of Rectal Endometriosis (ENDO-HIFU-R1)

Endometriosis, Rectum

France
Eurofarma Laboratorios S.A.

Recruiting

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment (ESPIRE)

Asthma Copd

Brazil
Eurofarma Laboratorios S.A.

Recruiting

Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer

Advanced Prostate Cancer

India
EDAP TMS S.A.

Active, not recruiting

Evaluation of the Efficacy of HIFU Treatment on Rectal Endometriosis Symptoms. (ENDO-HIFU-R2)

Endometriosis

France
IBSS Biomed S.A.

Active, not recruiting

Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. (Clodivac)

Tetanus | Diphtheria

Poland
ADC Therapeutics S.A.

Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

Advanced Solid Tumors

United States, Spain, United Kingdom
Arafarma Group, S.A.

Completed

Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients. (MANOTRAS)

Kidney Transplant Infection

Spain
Laboratorios Hipra, S.A.

Completed

Safety and Immunogenicity Study of Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Adult Healthy Volunteers (COVID-19)

Covid19 | SARS CoV 2 Infection

Spain
Arafarma Group, S.A.

Completed

Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Lithotripsy. (FAGOTRICIA)

Nephrolithiasis | Lithiasis

Spain
Arafarma Group, S.A.

Completed

Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement (FIBROFIN)

Fibromyalgia

Spain
Apsen Farmaceutica S.A.

Completed

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

Vertigo, Peripheral

Brazil
Aquilon Pharmaceuticals S.A.

Completed

Single-dose AQ001S PK Study in Healthy Volunteers (BORA)

Pharmacokinetics

Bulgaria
Bone Therapeutics S.A

Terminated

Study on Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head

Osteonecrosis of the Femoral Head
Apsen Farmaceutica S.A.

Withdrawn

Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease

Vertigo | Meniere Disease | Vertigo Vestibular
Eurofarma Laboratorios S.A.

Withdrawn

A Parallel-group Active Comparator, Double-blind, Multicenter, Randomized, Double-blind, Phase III Clinical Study (SAVE)

Knee Osteoarthritis
Laboratorios Andromaco S.A.

Completed

Bioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product

Bioequivalence

India
Laboratorios Andromaco S.A.

Completed

Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product

Bioequivalence

India
Bone Therapeutics S.A

Completed

Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures

Long Bone Delayed-Union Fracture
ADC Therapeutics S.A.

Completed

Study of ADCT-301 in Patients With Relapsed or Refractory Hodgkin and Non-Hodgkin Lymphoma

Hodgkin Lymphoma | Non-Hodgkin Lymphoma

United States, United Kingdom
HTL-Strefa S.A.

Completed

Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test C)

Accident Injury

United States
ADC Therapeutics S.A.

Terminated

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)

Acute Lymphoblastic Leukemia

United States
ADC Therapeutics S.A.

Completed

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | Burkitt's Lymphoma | Lymphoma, Marginal Zone

United Kingdom, United States, Italy
ADC Therapeutics S.A.

No longer available

Loncastixumab Tesirine (ADCT-402) Expanded Access Program (EAP) for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Genesis Pharma S.A.

Completed

Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions (POWERFUL)

Relapse/Refractory Multiple Myeloma

Greece
Laboratorios Andromaco S.A.

Completed

Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding Conditions

Bioequivalence

Chile
Laboratorios Andromaco S.A.

Completed

Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions

Bioequivalence

Chile
Amyndas Pharmaceuticals S.A.

Unknown

A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE) (SAVE)

Acute Respiratory Distress Syndrome Due to SARS-CoV-2 Infection (Severe COVID19)
Genesis Pharma S.A.

Completed

A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece (beYOND-STS)

Advanced Soft Tissue Sarcoma

Greece
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
Bone Therapeutics S.A

Terminated

Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases

Rheumatoid Arthritis | Spondylarthritis | Psoriatic Arthritis
Laboratorios Andromaco S.A.

Completed

Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product

Bioequivalence

Chile
Almirall, S.A.
Allergan

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Acne Vulgaris

United States
HTL-Strefa S.A.

Completed

The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
Laboratorios Andromaco S.A.

Completed

Bioavailability of Dienogest 2.0 mg With Regards to Reference Product

Bioequivalence

Chile
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis (RINEX50)

Rhinitis, Allergic, Perennial

Brazil
Glenmark Specialty S.A.

Completed

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

United States

3

Subscribe